Form Ds provide information on individual, unregistered securities offerings.
Search by Recipient Name or Primary Issuer:
| Recipient | CRD | Primary Issuer | CIK | Filing Date | Form Type | Total Offering Amount | Total Amount Sold |
|---|---|---|---|---|---|---|---|
| FINALIS SECURITIES LLC | 305908 | Nexben Inc. | 1736470 | 05/08/2023 | D/A | $28,176,656 | $21,459,215 |
| FINALIS SECURITIES LLC | 305908 | Supply Change Capital Fund I LP | 1863949 | 07/01/2022 | D/A | Indefinite | $20,075,081 |
| FINALIS SECURITIES LLC | 305908 | Elicio Therapeutics, Inc. | 1555192 | 11/18/2021 | D/A | $15,000,000 | $14,470,000 |
| FINALIS SECURITIES LLC | 305908 | Elicio Therapeutics, Inc. | 1555192 | 11/12/2021 | D/A | $15,000,000 | $14,470,000 |
| FINALIS SECURITIES LLC | 305908 | LMP Real Estate, L.P. | 1886461 | 03/23/2022 | D/A | $50,000,000 | $10,600,000 |
| FINALIS SECURITIES LLC | 305908 | 3G Fund 13, LLC | 1939876 | 12/28/2022 | D/A | Indefinite | $8,000,000 |
| FINALIS SECURITIES LLC | 305908 | Ashcroft Value-Add Fund III, LP | 1954888 | 12/16/2022 | D/A | $150,000,000 | $7,859,340 |
| FINALIS SECURITIES LLC | 305908 | Anacove, LLC | 1919144 | 06/08/2022 | D/A | $2,306,560 | $2,306,560 |
| FINALIS SECURITIES LLC | 305908 | Stingray Therapeutics, Inc. | 1759143 | 05/26/2021 | D/A | $3,000,000 | $1,510,272 |
| FINALIS SECURITIES LLC | 305908 | Smith Medical Holdings Inc. | 1953915 | 01/18/2023 | D/A | $8,500,000 | $675,000 |